With that in mind, we explored a publicly available dataset on breast cancer and identified that ER-negative, RANK-c positive samples presented with reduced phosphorylation of EGFR protein, corroborating our previous findings on RANK-c mode of action on EGFR. This evidence concerns the gene ESR1 and breast cancer.